People

 


 

Kyle Peterson

Managing Director
kyle.peterson@fsg-impact.org

Since 2002, Kyle has managed over 50 consulting projects for FSG in the areas of strategy, program design, operations and evaluation. Building on more than 20 years of international development experience, Kyle has led many of the firm's global health and global development engagements. He has presented and published numerous articles related to global development, global health, strategic CSR and organizational alignment.

Prior to joining FSG, Kyle served as a strategy consultant at OnTheFrontier, a former Monitor Group company. There he co-authored a major regional economic study with Harvard Professor Michael Porter and advised Paul Kagame, President of Rwanda, on the country's future economic strategy. Kyle was also country director in Zimbabwe and Rwanda for Population Services International, where he managed a $20 million program and launched a number of health product "firsts" on the continent: mass marketed insecticide treated mosquito nets, female condoms, and a novel network of HIV/AIDS voluntary counseling and testing centers.

Kyle is a board member of AllWorld Network, the sponsor of the 100 fastest growing small business lists in emerging markets such as Saudi Arabia and South Africa. He is also a Philanthropy Advisory Service (PAS) organizational review board member for FasterCures, a nonprofit dedicated to accelerating R&D for debilitating diseases around the world.

Kyle holds an M.B.A. and an M.P.A., cum laude, from the University of Texas at Austin and a B.A. in International Studies, cum laude, from the American University.

 

 

 

Representative Clients

Bill & Melinda Gates Foundation

The David and Lucille Packard Foundation

Institute for OneWorld Health

Management Sciences for Health

Merck

Pfizer

Shell


Ideas

Lobbying for Good
The power of socially responsible lobbying, SSIR Winter 09

The Female Condom
Increasing the impact of HIV/AIDS prevention technologies

PDP Performance Measurement
Improving evaluations of product development partnerships

Improving Access to Drugs
Leveraging the pharmaceutical industry on issues of drug access

Success as an Intermediate Goal
Medicines for Malaria Ventures and their new approach to performance measurement

 

Speaking Engagements

HBS Social Enterprise Conference

International Corporate Citizenship Conference

Gifts in Kind International

Clinton Global Health Summit